Tianjin Anding Hospital

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Berberine Effects on Clinical Symptoms and Metabolic Disturbance in Patients With Schizophrenia

Not Applicable

Completed

Conditions: Schizophrenia
Therapeutics

Interventions: Drug: Berberine
Drug: atypical antipsychotic
Drug: placebo

First Posted Date: 2018-06-07

Last Posted Date: 2023-07-25

Lead Sponsor: Tianjin Anding Hospital

Target Recruit Count: 65

Registration Number: NCT03548155

Berberine Treat Metabolic Syndrome in Schizophrenia

Not Applicable

Completed

Conditions: Metabolic Syndrome
Female
Schizophrenia

Interventions: Drug: berberine

First Posted Date: 2017-08-16

Last Posted Date: 2018-04-25

Lead Sponsor: Tianjin Anding Hospital

Target Recruit Count: 36

Registration Number: NCT03251716

Locations: 🇨🇳
Tianjin Anding Hospital, Tianjin, Tianjin, China

N-Acetyl Cysteine Supplementation in Therapy Refractory Major Depressive Disorders

Not Applicable

Conditions: Major Depressive Disorders

Interventions: Drug: placebo comparator of N-acetylcysteine
Drug: N-acetylcysteine

First Posted Date: 2016-11-23

Last Posted Date: 2022-09-22

Lead Sponsor: Tianjin Anding Hospital

Target Recruit Count: 200

Registration Number: NCT02972398

Locations: 🇨🇳
Tianjin Anding Hospital, Tianjin, Tianjin, China

Berberine Effect on Cytokine, CRP, Metabolic Disturbance as an Adjunctive Therapy in Schizophrenia Patients

Not Applicable

Completed

Conditions: Schizophrenia

Interventions: Drug: Placebo
Drug: Berberine

First Posted Date: 2016-10-18

Last Posted Date: 2018-05-17

Lead Sponsor: Tianjin Anding Hospital

Target Recruit Count: 100

Registration Number: NCT02936414

Locations: 🇨🇳
Tianjin Anding Hospital, Tianjin, Tianjin, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy